Altimmune, Inc. (ALT)
4.51
+0.13
(+2.97%)
USD |
NASDAQ |
Feb 23, 16:00
4.51
0.00 (0.00%)
After-Hours: 16:46
Altimmune Market Cap : 564.79M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 551.92M |
| Actinium Pharmaceuticals, Inc. | 32.91M |
| Aldeyra Therapeutics, Inc. | 300.21M |
| Viking Therapeutics, Inc. | 3.982B |
| Seres Therapeutics, Inc. | 71.17M |
Market Cap Related Metrics
| PS Ratio | 17910.57 |
| Price to Book Value | 3.043 |
| Price | 4.51 |
| Earnings Yield | -23.70% |